Concepedia

Elacridar enhances the cytotoxic effects of sunitinib and prevents multidrug resistance in renal carcinoma cells

Hiromi Sato, Sana Siddig, Miaki Uzu, Sayumi Suzuki, Yuki Nomura, Tatsuro Kashiba, Keisuke Gushimiyagi, Yuko Sekine, Tomoya Uehara, Yasushi Arano,

European Journal of Pharmacology · 2014 · 40 citations · 27 references

DOI

Concepts

References

27

Sunitinib versus Interferon Alfa in Metastatic Renal-Cell Carcinoma

Robert J. Motzer, Thomas E. Hutson, Piotr Tomczak et al. · New England Journal of Medicine · 2007 · 5.8K citations · Full text

, , +14

Improved Identification of von Hippel-Lindau Gene Alterations in Clear Cell Renal Tumors

Michael L. Nickerson, Erich Jaeger, Yangu Shi et al. · Clinical Cancer Research · 2008 · 605 citations · Full text

, , +17

In vitro and in vivo reversal of multidrug resistance by GF120918, an acridonecarboxamide derivative.

François Hyafil, Catherine Vergely, Philippe Vignaud et al. · PubMed · 1993 · 529 citations

, , +11

Functional imaging of multidrug-resistant P-glycoprotein with an organotechnetium complex.

David Piwnica‐Worms, Mark L. Chiu, Mark Budding et al. · PubMed · 1993 · 517 citations

, , +14

Imatinib mesylate (STI571) is a substrate for the breast cancer resistance protein (BCRP)/ABCG2 drug pump

Herman Burger, Hans van Tol, Antonius W.M. Boersma et al. · Blood · 2004 · 415 citations · Full text

, , +11